Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Quadrant licenses imaging portfolio to Upperton:

This article was originally published in Clinica

Executive Summary

UK development-stage imaging contrast agent company Upperton has licensed patents and assignments from fellow UK company Quadrant Healthcare. Upperton says that the intellectual property will enable it to proceed rapidly on a number of key projects, including MRI and ultrasound imaging. Quadrant is a drug delivery company developing spray- and vacuum-dried saccharide coated glass nanoparticles whose shell erosion allows for time release drug delivery. In June, it divested three of its imaging patent portfolio to Acuson and licensed products for in vitro diagnostics to Becton Dickinson.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT074915

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel